Results 211 to 220 of about 272,037 (262)
Some of the next articles are maybe not open access.

Hereditary ovarian carcinoma

Seminars in Surgical Oncology, 1994
AbstractOvarian cancer is the leading cause of death from gynecologic cancer in the united states. Although the etiology of ovarian cancer is unknown, a number of factors including advancing age, nulliparity and environmental factors have traditionally been related to risk.
H H, Gallion, S A, Smith
openaire   +2 more sources

Hereditary Ovarian Carcinoma

Hematology/Oncology Clinics of North America, 1992
No woman is at greater risk for ovarian carcinoma than one who is a member of a hereditary ovarian carcinoma syndrome kindred and whose mother, sister, or daughter has been affected with this disease and with an integrally related hereditary syndrome cancer. This article surveys the existing understanding about hereditary ovarian carcinoma. Emphasis is
H T, Lynch, J F, Lynch
openaire   +2 more sources

Epithelial ovarian carcinoma

The Lancet, 1997
The low survival rate is related to the high proportion of women who have spread of disease beyond the ovaries at diagnosis—25%, 11%, 47%, and 17% of cases at stage I‐IV, respectively, according to International Federation of Gynaecological and Obstetrics (FIGO) staging ...
G B, Kristensen, C, Tropé
openaire   +2 more sources

Pathology of ovarian carcinoma

Hematology/Oncology Clinics of North America, 2003
Serous carcinoma is the most common type of ovarian cancer and usually is associated with peritoneal metastases and poor survival except for meticulously staged patients with tumors confined to the ovaries. Endometrioid and clear cell carcinomas account for most nonserous carcinomas and more often present with low-stage disease; survival for the ...
Jeffrey D, Seidman, Robert J, Kurman
openaire   +2 more sources

Grading of Ovarian Carcinomas

International Journal of Gynecological Pathology, 2000
Grading of ovarian carcinomas can have important implications for therapeutic decisions, in particular in International Federation of Gynecology and Obstetrics (FIGO) stage I. However, there are no universally accepted grading guidelines for this type of cancer. We applied the grading system suggested by Shimizu et al.
D, Mayr, J, Diebold
openaire   +2 more sources

Ovarian Carcinoma, Endometrial Carcinoma, and Pregnancy

Gynecologic Oncology, 1999
A 31-year-old G1 P0 patient with a history of infertility presented with light spotting and cramping at the end of her first trimester. An ultrasonogram at 19 weeks gestation revealed an intrauterine gestation of 21 weeks, a large leiomyoma, and a 8.9 x 6.8 cm complex left ovarian mass.
D L, Foersterling, J G, Blythe
openaire   +2 more sources

Tissue Antigens in Ovarian Carcinoma

Oncology, 2009
Five tissue antigens have been identified which appear in carcinoma arising in the ovary. Antisera to a variety of human tissues were absorbed with a saline extract of normal ovary as well as plasma; five distinct antigens (A1-A4, TA) were detected in ovarian tumor extracts as well as in normal tissues.
R M, Burton   +3 more
openaire   +3 more sources

Ovarian carcinoma

American Journal of Obstetrics and Gynecology, 1966
Dianna E. Van Orden   +3 more
openaire   +3 more sources

TREATMENT OF OVARIAN CARCINOMA

The Lancet, 1972
W, Barr   +10 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy